Antisense oligonucleotides against VR1

Details Antisense oligonucleotides against VR1 Antisense oligonucleotides against VR1

2003-03-03

2010-02-16

Angell, J. E (Department: 1635)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

Reexamination Certificate

active

07662948

ABSTRACT:
Antisense oligodeoxynucleotides against VR1, corresponding nucleotide constructs, cells containing said nucleotide constructs, pharmaceutical and diagnostic substances, uses thereof in pain therapy, and methods for diagnosing symptoms related to VR1 and for identifying pain-modulating substances.

REFERENCES:
patent: 5744308 (1998-04-01), Guillou-Bonnici et al.
patent: 6278038 (2001-08-01), Cone et al.
patent: 6335180 (2002-01-01), Julius et al.
patent: 6482611 (2002-11-01), Cortright et al.
patent: 6566127 (2003-05-01), Pavco et al.
patent: 0 943 683 (1999-09-01), None
patent: 2 346 882 (2000-08-01), None
patent: WO 9846272 (1998-10-01), None
patent: WO 99/09140 (1999-02-01), None
patent: WO 99/37675 (1999-07-01), None
patent: WO 00/22121 (2000-04-01), None
patent: WO 00/29577 (2000-05-01), None
patent: WO 00/32766 (2000-06-01), None
patent: WO 00/63415 (2000-10-01), None
patent: WO 03018631 (2003-03-01), None
Soares et al. Construction and characterization of a normalized cDNA library Sep. 1995, Proc. Natl. Acad. Sci. vol. 91, pp. 9228-9232.
Gomez-Navarro et al. Gene therapy for cancer 1999, European Journal of Cancer vol. 35(6): pp. 867-885.
Agrawal et al. Antisense therapeutics: is it as simple as complementary base recognition? 2000 Mol. Med. Today: Reviews. vol. 61, pp. 72-81.
Opalinska et al. Nucleic acid therapeutics: basic principlese and recent applications. 2002 Nature Reviews: Drug Discovery vol. 1, pp. 503-514.
Jen et al. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies 2000 Stem Cells vol. 18, pp. 307-319.
Crooke, S. Progress in antisense technology 2004 Annu. Rev. Med. vol. 55, pp. 61-95.
Santoro et al. A general purpose RNA cleaving DNA-enzyme 1997 Proc. Nat.. Acad. Sci. vol. 94: pp. 4262-4266 (see in particular figure 2).
Simoncsits et al. Synthesis of pppGpN type dinucleotide derivatives: the 5′ end sequence of some RNAs. 1975 Nuc. Acids. Res. vol. 2, No. 2, pp. 257-263.
Sakai, Y. et al. Journal of Fermentation and Bioengineering, 1998; vol. 85(2), pp. 138-143.
Kurreck et al. “Comparative Study of DNA Enzymes and Ribozymes against the Same full-length Messenger RNA of the Vanilloid Receptor Subtype I”The Journal of Biological Chemistry, vol. 277, No. 9, (2002) pp. 7099-7107. XP-001068907.
Caterina et al. “The capsaicin receptor: a heat-activated ion channel in the pain pathway”Nature, vol. 389, pp. 816-824 (1997). XP002942960.
Goila et al. “Sequence specific cleavage of the HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: inhibition of the coreceptor function by DNA-enzyme”FEBS Letters436 1998) pp. 233-238.

Affiliated with

Also associated with

Rating

Antisense oligonucleotides against VR1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense oligonucleotides against VR1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides against VR1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4187663